Paiva, Bruno
The Cima Universidad de Navarra,
Spain
2025 Rank: 61474
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1175 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 61474 | 60463 |
| Total Cites | 2309 | 2688 |
| H-index | 20 | 23 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 223 | 241 |
| Number of Single+First+Last Authored Papers | 52 | 52 |
| Total Cites to Single+First+Last Authored Papers | 326 | 361 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1340 | 1485 |
| Ratio of Total Citations to Distinct Citing Papers | 1.72 | 1.81 |
| Self-Citation Percentage |
14.10%
|
|
Paiva, Bruno
Instituto de Investigación Sanitaria de Navarra,
Spain
2024 Rank: 78609
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1578 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78609 | 63840 |
| Total Cites | 1932 | 2385 |
| H-index | 18 | 21 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 186 | 224 |
| Number of Single+First+Last Authored Papers | 49 | 49 |
| Total Cites to Single+First+Last Authored Papers | 283 | 346 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1154 | 1314 |
| Ratio of Total Citations to Distinct Citing Papers | 1.67 | 1.82 |
| Self-Citation Percentage |
18.99%
|
|
Paiva, Bruno
The Cima Universidad de Navarra,
Spain
2023 Rank: 68431
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1529 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 68431 | 61702 |
| Total Cites | 1947 | 2376 |
| H-index | 19 | 21 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 30 | 30 |
| Total Cites to Single+First Authored Papers | 234 | 275 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 325 | 392 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1138 | 1288 |
| Ratio of Total Citations to Distinct Citing Papers | 1.71 | 1.84 |
| Self-Citation Percentage |
18.06%
|
|
Paiva, Bruno
The Cima Universidad de Navarra,
Spain
2022 Rank: 65474
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1604 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65474 | 58951 |
| Total Cites | 1902 | 2339 |
| H-index | 20 | 22 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 236 | 289 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 318 | 388 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1191 | 1347 |
| Ratio of Total Citations to Distinct Citing Papers | 1.60 | 1.74 |
| Self-Citation Percentage |
18.68%
|
|
Paiva, Bruno
The Cima Universidad de Navarra,
Spain
2021 Rank: 83903
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1867 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 83903 | 78164 |
| Total Cites | 2485 | 3066 |
| H-index | 23 | 26 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 28 | 28 |
| Total Cites to Single+First Authored Papers | 322 | 385 |
| Number of Single+First+Last Authored Papers | 35 | 35 |
| Total Cites to Single+First+Last Authored Papers | 400 | 480 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1619 | 1845 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.66 |
| Self-Citation Percentage |
18.95%
|
|
Paiva, Bruno
Centro de Investigacion Medica Aplicada,
Spain
2020 Rank: 79975
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1671 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79975 | 79449 |
| Total Cites | 1592 | 1977 |
| H-index | 18 | 20 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 266 | 304 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 303 | 348 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1039 | 1191 |
| Ratio of Total Citations to Distinct Citing Papers | 1.53 | 1.66 |
| Self-Citation Percentage |
19.47%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.